Not finding it? Sign in to also search OpenAlex live.
-
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study2023 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Gustavo Citera, Kuan‐Hsiang Gary Huang, +6 more
4citations -
D92-01 Home Spirometry to Assess Treatment Response in Pulmonary Sarcoidosis: An Analysis of the Predmeth Trial2026 American Journal of Respiratory and Critical Care Medicine article Medicine Sarcoidosis and Beryllium Toxicity Research
D Simon, Catharina C. Moor, Vivienne Kahlmann, Rémy L.M. Mostard, H.N.A.J. van Rijswijk, Jan van der Maten, +4 more
0citations -
POS1325 UNLOCKING THE POTENTIAL OF LIPIDOMICS FOR PREDICTIVE TREATMENT STRATEGIES IN PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Mieke L M Bentvelzen, Yuhong Zhang, Amy C. Harms, H.E. Vonkeman, Shasti C. Mooij, Lydia G. Schipper, +3 more
0citations -
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
Ulf Sundin, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Joseph Sexton, Lena Bugge Nordberg, Hilde Berner Hammer, +4 more
29citations -
Induction of Cure in Early Arthritis (I CEA): study protocol for an investigator-initiated randomized single-blind clinical trial with open-label extension to compare three treatment strategies in patients with newly diagnosed undifferentiated arthritis
Sytske Anne Bergstra, Lotte van Ouwerkerk, Isabell S Nevins, Joy Ardjuna van der Pol, G S Helmich, I Hest, +9 more
1citations -
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer, +43 more
44citations -
TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
Ellis Niemantsverdriet, Yousra J. Dakkak, Leonie E. Burgers, Femke Bonte‐Mineur, Gerda M. Steup‐Beekman, Sjoerd M. van der Kooij, +4 more
35citations -
Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL ( TREatment of ATopic eczema, the Netherlands) registry2023 Journal of the European Academy of Dermatology and Venereology article Medicine Dermatology and Skin Diseases Open access
Annelie H. Musters, Florine L van Lookeren, Lian F. van der Gang, M.A. Middelkamp‐Hup, Angela L. Bosma, Naomi T. Jessurun, +6 more
15citations -
PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
Hamit Harun Dağ, Agnes E M Looijen, Harald E. Vonkeman, Annemiek Willemze, Lindy‐Anne Korswagen, Roos C Padmos, +8 more
2citations -
Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study2021 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access
Julia Spierings, Hilde H. Nienhuis, Eva van Lieshout, Jacob M. van Laar, Arwen H. Pieterse
2citations -
Successful discontinuation of oral glucocorticoids after short-term bridging therapy in patients with newly diagnosed rheumatoid arthritis2026 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Gina Hetland Brinkmann, Nina Paulshus Sundlisæter, Lena Bugge Nordberg, Joseph Sexton, Eirik Ikdahl, Anna‐Birgitte Aga, +4 more
1citations -
ABS0957 CAN TREATMENT EXPECTATIONS OR TREATMENT ITSELF IN PATIENTS WITH ARTHRALGIA SUSPICIOUS FOR PROGRESSION TO RHEUMATOID ARTHRITIS IMPROVE ILLNESS PERCEPTIONS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Simonetta R G van Griethuysen, Quirine A Dumoulin, Elise van Mulligen, Annette H M van der Helm–van Mil
0citations -
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update2024 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, +30 more
380citations -
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access cited by 1 patent
Andreas Kerschbaumer, Alexandre Rocha Sepriano, Josef S Smolen, Désirée M F M van der Heijde, Maxime Dougados, Ronald van Vollenhoven, +6 more
292citations -
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis2022 Annals of the Rheumatic Diseases review Medicine Rheumatoid Arthritis Research and Therapies Open access
Andreas Kerschbaumer, Alexandre Rocha Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée M F M van der Heijde, Roberto Felice Caporali, +11 more
181citations -
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update2026 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Josef S Smolen, Christopher J. Edwards, Victoria Konzett, Faidra Laskou, Daniel Aletaha, Roberto Felice Caporali, +44 more
95citations -
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer2021 British Journal of Pharmacology article Immunology and Microbiology Immune cells in cancer Open access
Rômulo S. Cavalcante, Uta Ishikawa, Emanuell S. Silva, Arnóbio Antônio da Silva-Júnior, Aurigena Antunes de Araújo, Luis Javier Cruz, +2 more
73citations